News
Videos
Conferences
Events
Resources
Subscribe

|Videos|October 23, 2015

Expert Panel Discusses Nausea and Vomiting

Episodes in this series

EP. 1 Expert Panel Discusses Nausea and Vomiting

EP. 1 Expert Panel Discusses Nausea and Vomiting

EP. 2 Proper Communication With Care Team

EP. 2 Proper Communication With Care Team

EP. 3 Preventing Complications of CINV

EP. 3 Preventing Complications of CINV

EP. 4 How to Combat CINV

EP. 4 How to Combat CINV

EP. 5 Psychological Effects of Nausea and Vomiting

EP. 5 Psychological Effects of Nausea and Vomiting

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Fred Batchelor, a liver cancer survivor, shares lessons on advocacy and why World Cancer Day keeps patients, families and their communities engaged: © stock.adobe.com.

Discussing Community and the Importance of World Cancer Day

February 4th 2026

In honor of World Cancer Day, CURE sat down with experts and advocates to discuss the importance of this initiative.

World Cancer Day Highlights Awareness and Global Collaboration

February 4th 2026

Biotin supplements used for cancer-related hair loss may interfere with key blood tests, risking inaccurate results and altered care decisions: © The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

Biotin Supplements May Complicate Cancer Care, Research Shows

February 2nd 2026

Dr. Brittany Dulmage explains how biotin can interfere with lab testing during cancer care: © The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

Biotin, Lab Interference and Safer Options for Cancer-Related Hair Loss

January 30th 2026

As patients with advanced cancer near the end of life, reducing unnecessary medications may help prioritize comfort, quality of life, and symptom relief: © stock.adobe.com

Rethinking Medications at the End of Life for Patients With Advanced Cancer

January 27th 2026

Trending on CURE

FDA Updates Safety Warnings for Common Chemotherapy Drugs

KTX-1001 Elicits Responses in Some With Multiple Myeloma

FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma

New Combination Treatment Approach Studied in Pancreatic Cancer

Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma